Regular aspirin use may reduce risk of dying from prostate cancer
Regular aspirin use may reduce risk of dying from prostate cancer
ASCO GU: Advances in prostate cancer from day one
Alisertib for pretreated urothelial cancer
Link between non-aspirin NSAID use and risk of developing renal cell cancer
Brentuximab vedotin as salvage therapy for men with relapsed germ-cell tumours
Actionable targets in patients with cisplatin-resistant advanced germ cell tumours
The work and aims of the Association of Cancer Physicians
Breast cancer screening in Morocco
Post-translational modification (PTM) profiling – a novel tool for mapping the PTM landscape in cancer
What does the iManageCancer project hope to achieve?
EurocanPlatform 'Biomarkers, screening and prevention in cancer' Special Issue
Cancer diagnosis and evaluation of treatment in the genomic era